TWIST BIOSCIENCE CORP (TWST:NASDAQ)
$62.61 0.73 (1.1797%)
Analysed TWIST BIOSCIENCE CORP (TWST:NASDAQ) News Sources
Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026
21-04-2026
yahoo.com
Assessing Twist Bioscience (TWST) Valuation After Insider Sale And Recent Q1 FY26 Optimism
25-02-2026
yahoo.com
Twist Bioscience Adds Invenra Bispecific Platform To Broaden Discovery Opportunity
25-02-2026
yahoo.com
Twist Bioscience to Present at Upcoming Investor Conferences
18-02-2026
yahoo.com
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement
17-02-2026
yahoo.com
Biotech Beat Nvidia in 2025. Can It Do It Again?
11-02-2026
fool.com
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
10-02-2026
yahoo.com
Twist Bioscience Annual Meeting: Shareholders Elect Directors, Approve Pay and EY Auditor Ratification
09-02-2026
marketbeat.com
Twist Bioscience Guidance Lift Puts AI Demand And Risks In Focus
05-02-2026
yahoo.com
Assessing Twist Bioscience (TWST) Valuation After Recent Share Price Momentum
04-02-2026
yahoo.com
What is the current price of TWIST BIOSCIENCE CORP (TWST:NASDAQ)?
The current price of TWIST BIOSCIENCE CORP (TWST:NASDAQ) is $62.61.
TWIST BIOSCIENCE CORP (TWST:NASDAQ) absolute price change since previous trading day?
The absolute price change of TWIST BIOSCIENCE CORP (TWST:NASDAQ) since the previous trading day is $0.73.
TWIST BIOSCIENCE CORP (TWST:NASDAQ) percentage price change since previous trading day?
The percentage price change of TWIST BIOSCIENCE CORP (TWST:NASDAQ) since the previous trading day is 1.1797%.
What is the most recent average sentiment score for TWIST BIOSCIENCE CORP (TWST:NASDAQ)?
The most recent average sentiment score for TWIST BIOSCIENCE CORP (TWST:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for TWIST BIOSCIENCE CORP (TWST:NASDAQ)?
The most recent sentiment for TWIST BIOSCIENCE CORP (TWST:NASDAQ) is .
SEC-8K** Filing Available For TWIST BIOSCIENCE CORP (TWST:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.